1h Free Analyst Time
The artificial bone market is forecasted to grow by USD 208 million during 2023-2028, accelerating at a CAGR of 9.44% during the forecast period. The report on the artificial bone market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising geriatric population globally, increasing prevalence of bone disorders and injuries, and rising awareness and accessibility to advanced medical treatments.
The artificial bone market is segmented as below:
By Material
- Ceramics
- Hydroxyapatite
- Composite
- Polymer
- Others
By End-user
- Hospitals
- Specialty clinics
- Research organization
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the artificial bone market covers the following areas:
- Artificial bone market sizing
- Artificial bone market forecast
- Artificial bone market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Material
7 Market Segmentation by End-user
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Opportunity/Restraints
11 Competitive Landscape
12 Competitive Analysis
13 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global artificial bone market: Aditus Medical GmbH, AlloSource, Bando Chemical Industries Ltd., Baxter International Inc., Biomatlante SAS, Curasan Inc., Graftys SA, HOYA CORP., Johnson and Johnson Services Inc., Koninklijke DSM NV, Maxigen Biotech Inc., Medtronic Plc, Nuvasive Inc., Orthofix Medical Inc., Shenzhen Mindray BioMedical Electronics Co. Ltd, Smith and Nephew plc, Stryker Corp., Xtant Medical Holdings Inc., Ziacom Medical S.L., and Zimmer Biomet Holdings Inc..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is high prevalence of osteoporosis."
According to the report, one of the major drivers for this market is the rising geriatric population globally.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Aditus Medical GmbH
- AlloSource
- Bando Chemical Industries Ltd.
- Baxter International Inc.
- Biomatlante SAS
- Curasan Inc.
- Graftys SA
- HOYA CORP.
- Johnson and Johnson Services Inc.
- Koninklijke DSM NV
- Maxigen Biotech Inc.
- Medtronic Plc
- Nuvasive Inc.
- Orthofix Medical Inc.
- Shenzhen Mindray BioMedical Electronics Co. Ltd
- Smith and Nephew plc
- Stryker Corp.
- Xtant Medical Holdings Inc.
- Ziacom Medical S.L.
- Zimmer Biomet Holdings Inc.
